Scientists Launch Global Trial to Find First Effective Treatment for Bundibugyo Ebola

Researchers hope the international study will identify targeted therapies for one of the least understood Ebola virus strains.

International researchers have begun enrolling patients in a major clinical trial designed to identify the first effective treatment for Bundibugyo virus disease, a rare form of Ebola that has caused several outbreaks in Africa.

The study is being coordinated with support from the World Health Organization and brings together researchers, hospitals and public health agencies from multiple countries.

While vaccines and treatments have been developed for other Ebola strains, scientists say evidence for Bundibugyo virus remains limited. The new trial aims to evaluate whether existing antiviral medicines or experimental therapies can reduce severe illness and improve survival.

Researchers believe the findings could significantly strengthen global preparedness for future Ebola outbreaks while helping health authorities respond more effectively during public health emergencies.

The WHO says international collaboration remains essential for combating emerging infectious diseases and accelerating access to safe, evidence-based treatments.